Status:
RECRUITING
CuePD: Investigating the Effect of Personalised Auditory Cueing on Gait in Parkinson's Disease
Lead Sponsor:
Northumbria University
Collaborating Sponsors:
North Tyneside General Hospital
Northumbria Healthcare NHS Foundation Trust
Conditions:
Parkinson's Disease (PD)
Eligibility:
All Genders
50-85 years
Phase:
NA
Brief Summary
Parkinson's Disease (PD) is a major cause of disability, globally. PD affects a person's movement speed, fluency, quality, and ease of walking. PD has the fastest-growing incidence rate, with its prev...
Detailed Description
A researcher will contact identified participants to explain the study further and provide the approved patient information sheet (PIS, via post or email - subject to the potential participant's prefe...
Eligibility Criteria
Inclusion
- Able to walk unaided.
- Diagnosis of idiopathic PD, as defined by the UK Brain Bank criteria.
- Score ≥21/30 on Montreal Cognitive Assessment (MoCA) which is used to classify non-demented PD (PD dementia is \<21/30).
Exclusion
- Non-English speakers
- History of stroke, traumatic brain injury or other neurological disorders (other than PD)
- Acute lower back or lower extremity pain, peripheral neuropathy, and musculoskeletal disorders that would affect tasks.
- Unstable medical condition including cardio-vascular instability in the past 6 months
- Unable to comply with the testing protocol or currently participating in another interfering research project
Key Trial Info
Start Date :
November 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06941779
Start Date
November 21 2024
End Date
December 1 2025
Last Update
April 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Northumbria University
Newcastle, United Kingdom
2
North Tyneside General Hospital
North Shields, United Kingdom